Click here to load reader

Sera cue vc 18.1.16

  • View
    156

  • Download
    1

Embed Size (px)

Text of Sera cue vc 18.1.16

  • We provide a complete range of Pathological services

  • Vision:To be the leader in preventive healthcare, by using latest technology andemployees, who care

    Mission:To be the most trusted brand by individuals, for bringing world class, costeffective diagnostic care to their door step that will lead to their well beingand a healthy lifestyle.

    OUR VISION AND MISSION

  • Big and growing healthcare market >90% labs still with unorganized players Tier 2 and 3 cities not adequately covered by the larger players Opportunity to grow through franchise model

    Why we started Sera Cue?

  • MARKET LANDSCAPE

    Indian diagnostic Market Size : INR 250 bn. Market Size will reach INR 400 bn by 2018. More than 1 lac Pathological Labs in India Just 1% labs are accredited in India Organized labs account for just 8% of total market

    size.

    Source of data: Published data on Net & Journals

  • OUR GEOGRAPHICAL SPREAD

    Head Office : New DelhiCurrent Labs : 14Labs under Execution : 2Current Collection Centres : 45Current Lab Locations:

    Ludhiana, Saharanpur, Hyderabad,Gurgaon1,Gurgaon II, Faridabad,Vikaspuri , Shahadra, Rohini, Kalkaji,Sohna Road, Neemrana, Chandigarh

    Labs under Execution (To be launched in Next 30Days) :

    Ranibagh, East Delhi.

  • A LOOK AT OUR LABS

  • BUSINESS MODEL

    Expansion through Franchisee route(FOCO Model) Infrastructure + Franchisee Fee investment

    made by Franchisee Entire Equipment range arranged by Sera Cue

    Labs from reputed global manufacturers likeRoche, Beckman coulter, Horiba, RandoxDaytona.

    Entire Operations & Market penetrationhandled by Sera Cue including all operationalexpenses.

    Franchisee gets a flat payout of 25% on thetop line.

  • BUSINESS CASE FOR EACH LAB

    Manpower cost* 100000Electricity, maintenance 25000cost of reagents** 15-18%Marketing 30000Conveyance, miscellaneous 20000Sub-total 175000H.O. cost 10%Franchisee payout 100000Average revenue per customer 500Average number of customersper day for break-even 25

    *Includes cost of pathologist, Technician cum phlebotomist and Sales person** Depends on type of equipment and volume

    Note: All figures in INR, it takes 3-6 months for lab to break-even

  • MANAGEMENT TEAM

    Dilpreet SahiCEO

    Well known as the GoldenMan in financial circle,Dilpreet Sahi has workedfor renowned organizationslike ICICI, ABN AMRO,Barclays and BNP Paribas.Infact he was the youngestVP of ABN AMRO Bankworldwide. He isconsidered to be an experton infrastructure, logisticsand healthcare. He hashandled key portfoliosworth INR 45000 Crore.

    Col. Anvinder SinghDirector Strategy

    Col. Anvinder Singh isrecognized for exemplaryleadership skills in the IndianArmy. He was the COO ofIPL Cricket Team Kings XIfor 6 years. At SeraCue he isone of the shareholders andtakes care of overallstrategic direction.

    HM SinghCOO

    Considered to be acelebrity within thediagnostics fraternity, HMSingh is credited withbringing advancedtechnology in India throughvarious technicalcollaborations. He hasworked with leadingorganizations like Johnson& Johnson, Ranbaxy andNectar Life sciences.

    Arun BhardwajDirector & Mentor

    A renowned businessleader, Arun Bhardwaj isaccredited with launch ofseveral businesses fromscratch and helping themsucceed. He has leadershippositions in companies likeHCL, Ericsson and Airtel. AtSera Cue, he is the one ofthe shareholders & mentorof the organization.

  • WHY CHOOSE US?

    Passionate and Visionary Management Team Established proof of concept and

    Organization already on the path of EarlyGrowth Stage

    Business Model is based on at least 1 lab ineach district of India in order to providemost accurate/creditable test results ataffordable cost to Indian Consumers rightat their doorstep.

    World class equipments deployed by SeraCue Labs, with best TAT & accurate results.

    Quality of manpower and technical staff. Hunger for growth.

  • RECOGNISED AS EMERGING BRANDOF THE YEAR

  • Year Top line (INR Mln) EBITDA %

    2015 -16 35 to 40 Mln 10- 12%*

    2016 -17 240 Mln 20%

    2017 -18 500 Mln 25%

    2018 -19 800 Mln 30%

    KEY FINANCIAL PROJECTIONS

  • How much Capital do we wish to Raise ? USD 2.0 to 3.0 Million

    Fund Usage : 30% on Operations 20 % on Branding and Marketing 20% on Distribution network Expansion 10% on technology and accreditation 20% on Human Capital and Head Offfice

    FUNDING REQUIREMENTS

  • IPO

    Buy Back

    Sale to strategic Investor

    EXIT OPTIONS FOR VENTURE CAPITALISTS

  • Arun Bhardwaj Mobile: (91) 9810725825 Email: [email protected]

    For any Queries/ Inputs, please contact: